Lung Cancer

The FDA approved the first anti-PD-1 therapy to be administered in combination with standard chemotherapy for the treatment of non-small cell lung cancer.

Researchers examined the potential risk of cardiac injury following radiation therapy in patients with stage III non-small-cell lung cancer.

The FDA has approved a new drug for the treatment of patients with metastatic anaplastic lymphoma kinase-positive non-small cell lung cancer.

The FDA approved osimertinib for the treatment of patients with metastatic epidermal growth factor receptor T790M mutation-positive non-small cell lung cancer.

Researchers studied bronchial and nasal epithelial gene expression to see if lung damage related to smoking was detectable via nasal tissue swab.

The research presented at the International Association for the Study of Lung Cancer examined the relationship between nonsteroidal anti-inflammatory drugs and the risk of lung cancer using the data from...

A retrospective study found that new criteria for classifying lung nodules may substantially reduce the false-positive result rate in lung cancer screening.

The FDA is seeking a cap on nicotine levels in cigarettes and certain tobacco products at minimally or nonaddictive levels. This initiative, if finalized, would be what the FDA calls a “significant step”...